NCT02497846View on ClinicalTrials.gov

TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Crow's Feet Wrinkles
Interventions
DEVICE

TEOSYAL® PureSense Redensity [I]/MicronJet®

According the instruction of use, 3 injections of TEOSYAL® PureSense Redensity \[I\]will be performed all the 3 weeks. The used needle will be the MicronJet® microneedles for product injection. And the last visit (of control) will be performed 3 weeks after the last injection.

Trial Locations (1)

1206

Docteur MICHEELS, Geneva

All Listed Sponsors
lead

Teoxane SA

INDUSTRY

NCT02497846 - TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles | Biotech Hunter | Biotech Hunter